Study proposes a resilience approach for accurate diagnosis of HBV-related diseases through blood tests

Chronic hepatitis B virus (HBV) infection poses a significant threat to global public health, contributing to liver-related morbidity and mortality. The current diagnostic methods for HBV-related diseases, such as laboratory tests, ultrasounds, computed tomography (CT), and liver biopsies, often overlap and consume valuable medical resources. In response to this challenge, a team of researchers have developed an innovative and cost-effective method to diagnose and predict HBV-related diseases based on blood tests.